Biocompatibility and Alkaline Phosphatase Activity of Phosphorylated Chitooligosaccharides on the Osteosarcoma MG63 Cell Line
Source abstract
Abstract
Phosphorylated chitooligosaccharides (P-COS) were prepared using a H3PO4, P2O5, Et3PO4 and hexanol solvent system. The P-COS were characterized by Fourier Transform Infrared Spectroscopy (FT-IR), Thermo gravimetric-Differential Thermal Analyzer (TG-DTA), 13C NMR, 31P NMR, X-ray diffraction analysis, solubility studies, biocompatibility and Alkaline Phosphatase Activity (ALP). The results reveal that phosphorylation occurred at the C3 and C6 position of OH groups and the C2 position of NH2 group. FT-IR confirmed no decomposition in pyranose ring in P-COS even with heating and treatment in acidic conditions. The amorphous nature of P-COS was confirmed by X-ray diffraction analysis. Further, the biocompatibility and alkaline phosphatase activity of P-COS were checked against the osteosarcoma MG63 cell line at different concentrations and no cytotoxicity was observed. After 12 h and 24 h of incubation, the ALP activity of P-COS was higher compared with the control group. These results suggest that P-COS is a biocompatible material and in future P-COS could open up a number of promising pharmaceutical and clinical applications to mankind.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanocomposite Films for Food Packaging · biodegradable polymer synthesis and properties · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Pukyong National University, Busan 608-737, Korea
Marine Bioprocess Research Center, Pukyong National University, Busan 608-737, Korea
References (30)
Show source-provided references
1. Preparation of chitin and chitosan oligomers and their applications in physiological functional foods10.1081/FRI-100100286 ↗
2. Water-soluble chitosan derivatives as a BACE1 inhibitor10.1016/j.bmc.2005.07.004 ↗
3. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review10.1016/j.carbpol.2005.08.012 ↗
4. Chitosan composites for bone tissue engineering—An overview10.3390/md8082252 ↗
5. A review of chitin and chitosan applications10.1016/S1381-5148(00)00038-9 ↗
6. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications10.1016/j.ijbiomac.2008.09.007 ↗
7. Antimicrobial effect of chitooligosaccharides produced by bioreactor10.1016/S0144-8617(00)00200-9 ↗
8. Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection10.1080/10837450600940873 ↗
9. Review paper: chitosan derivatives as promising materials for controlled drug delivery10.1177/0885328208091562 ↗
10. Production of chitooligosaccharides using an ultrafiltration membrane reactor and their antibacterial activity10.1016/S0144-8617(99)00084-3 ↗
11. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems10.1016/j.fm.2008.05.003 ↗
12. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus10.1016/j.ultramic.2008.04.015 ↗
13. Study of the antibacterial effects of chitosans on Bacillus cereus (and its spores) by atomic force microscopy imaging and nanoindentation10.1016/j.ultramic.2009.03.015 ↗
14. Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose10.1016/S0008-6215(00)90359-8 ↗
15. Free radical scavenging properties of hetero-chitooligosaccharides using an ESR spectroscopy10.1016/j.fct.2003.10.001 ↗
16. Antioxidant activity of chitooligosaccharides upon two biological systems: Erythrocytes and bacteriophages10.1016/j.carbpol.2009.10.050 ↗
17. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-110.1016/j.bbagen.2006.08.021 ↗
18. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts10.1016/j.febslet.2006.04.015 ↗
19. Inhibitory Effect of Chitooligosaccharides on Matrix Metalloproteinase-9 in Human Fibrosarcoma Cells (HT1080)10.1007/s10126-006-6031-7 ↗
20. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats10.3748/wjg.v13.i5.725 ↗
21. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides10.1016/j.carres.2009.12.017 ↗
22. Anti-inflammatory effect of chitosan oligosaccharides in RAW 264.7 cells
23. Synthesis, characterization and drug delivery behaviors of new PCP polymeric micelles10.1016/j.carbpol.2006.10.019 ↗
24. Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification10.1016/j.bmc.2005.03.034 ↗
25. Inhibitory activity of phosphorylated chitooligosaccharides on the formation of calcium phosphate10.1016/j.carbpol.2005.03.014 ↗
26. Muraki, E. (2001). Chitooligosaccharide derivative. (6,197,942), U.S. Patent.
27. Synthesis of phosphorylated chitosan by novel method and its characterization10.1016/j.ijbiomac.2007.12.011 ↗
28. Chemical modification of chitosan by phosphorylation: an XPS, FT-IR and SEM study10.1163/156856205774576736 ↗
29. Venkatesan, J., Qian, Z.-J., Ryu, B., Ashok Kumar, N., and Kim, S.-K. (2010). Preparation and characterization of carbon nanotube-grafted-chitosan - Natural hydroxyapatite composite for bone tissue engineering. Carbohyd. Polym.10.1016/j.carbpol.2010.08.019 ↗
30. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements10.1016/S0142-9612(00)00413-0 ↗